Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells

Journal of Laryngology and Otology

Volumn 121, Issue 5, 2007, Pages 476-482

  Wang, Yan ^a   Duan, Hong Gang ^a   Chen, Shi Ming ^a   Xiao, Bo Kui ^a   Cheng, Jie ^a   Tao, Ze Zhang ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Caspase 3; Nasopharyngeal Neoplasms; Proliferating Cell Nuclear Antigen; Telomerase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; CYCLINE; MESSENGER RNA; MYC PROTEIN; SHORT HAIRPIN RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANTIGEN EXPRESSION; ARTICLE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; EXPRESSION VECTOR; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOLECULAR BIOLOGY; NASOPHARYNX CARCINOMA; NITROBLUE TETRAZOLIUM TEST; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RNA INTERFERENCE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; UPREGULATION; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL SURVIVAL; DNA-BINDING PROTEINS; HUMANS; LIPIDS; NASOPHARYNGEAL NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, CATALYTIC; TELOMERASE;

EID: 34249710222     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215106005019     Document Type: Article

References (20)

1. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-91
2. Oulton R, Harrington L. Telomeres, telomerase, and cancer: life on the edge of genomic stability. Curr Opin Oncol 2000;12:74-81
3. Liu Y, Snow BE, Hande MP, Yeung D, Erdmann NJ, Wakeham A et al. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol 2000;10:1459-62
4. Chang JT, Liao CT, Jung SM, Wang TC, See LC, Cheng AJ. Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues. Br J Cancer 2000;82:1946-51
5. Hwang CF, Su CY, Kou SC, Huang SC, Leung SW, Huang CM et al. Diagnostic usefulness of telomerase activity in nasopharyngeal carcinoma. Jpn J Cancer Res 2000;91:760-6
6. Artandi SE, DePinho RA. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr Opin Genet Dev 2000;10:39-46
7. Brachman DG. Molecular biology of head and neck cancer. Semin Oncol 1994;21:320-9
8. Chen SM, Tao ZZ, Hua QQ, Liu D, Chi HM, Cai Q. Inhibition of human telomerase reverse transcriptase in Hep-2 cells using short hairpin RNA expression vectors. Arch Otolaryngol Head Neck Surg 2006;132:200-5
9. Tao ZZ, Chen SM, Wu ZY, Xiao BK, Liu JF, Hou W. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA. J Laryngol Otol 2005;119:92-6
10. McCaul JA, Gordon KE, Clark LJ, Parkinson EK. Telomerase inhibition and the future management of head-and-neck cancer. Lancet Oncol 2002;3:280-8
11. Chow E, Payne D, O'Sullivan B, Pintilie M, Liu FF, Waldron J et al. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? Radiother Oncol 2002;63:269-74
12. Huncharek M, Rupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials. Am J Clin Oncol 2002;25:219-23
13. Saretzki G. Telomerase inhibition as cancer therapy. Cancer Lett 2003;194:209-19
14. Nguyen DC, Parsa B, Close A, Magnusson B, Crowe DL, Sinha UK. Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas. Int J Oncol 2003;22:1285-90
15. Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 2001;269:1-12
16. Latil A, Vidaud D, Valeri A, Fournier G, Viduad M, Lidereau R et al. hTERT expression correlates with MYC over-expression in human prostate cancer. Int J Cancer 2000;89:172-6
17. Sagawa Y, Nishi H, Isaka K, Fujito A, Takayama M. The correlation of TERT expression with c-myc expression in cervical cancer. Cancer Lett 2001;168:45-50
18. Chen Z, Koeneman KS, Corey DR. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells. Cancer Res 2003;63:5917-25
19. Borriello A, Roberto R, Della Ragione F, Iolascon A. Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma. Haematologica 2002;87:196-214
20. Xiang H, Wang J, Mao YW, Li DW. hTERT can function with rabbit telomerase RNA: regulation of gene expression and attenuation of apoptosis. Biochem Biophys Res Commun 2000;278:503-10